190 related articles for article (PubMed ID: 22891709)
1. Discrimination of ligands with different flexibilities resulting from the plasticity of the binding site in tubulin.
Chakraborti S; Chakravarty D; Gupta S; Chatterji BP; Dhar G; Poddar A; Panda D; Chakrabarti P; Ghosh Dastidar S; Bhattacharyya B
Biochemistry; 2012 Sep; 51(36):7138-48. PubMed ID: 22891709
[TBL] [Abstract][Full Text] [Related]
2. Different kinetic pathways of the binding of two biphenyl analogues of colchicine to tubulin.
Dumortier C; Gorbunoff MJ; Andreu JM; Engelborghs Y
Biochemistry; 1996 Apr; 35(14):4387-95. PubMed ID: 8605187
[TBL] [Abstract][Full Text] [Related]
3. Dynamic and Static Water Molecules Complement the TN16 Conformational Heterogeneity inside the Tubulin Cavity.
Majumdar S; Maiti S; Ghosh Dastidar S
Biochemistry; 2016 Jan; 55(2):335-47. PubMed ID: 26666704
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.
Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N
J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059
[TBL] [Abstract][Full Text] [Related]
5. Oxalone and lactone moieties of podophyllotoxin exhibit properties of both the B and C rings of colchicine in its binding with tubulin.
Gupta S; Das L; Datta AB; Poddar A; Janik ME; Bhattacharyya B
Biochemistry; 2006 May; 45(20):6467-75. PubMed ID: 16700557
[TBL] [Abstract][Full Text] [Related]
6. Electrostatic contributions to colchicine binding within tubulin isotypes.
Huzil JT; Barakat K; Tuszynski JA
Electromagn Biol Med; 2009; 28(4):355-64. PubMed ID: 20017626
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence spectroscopic methods to analyze drug-tubulin interactions.
Bhattacharyya B; Kapoor S; Panda D
Methods Cell Biol; 2010; 95():301-29. PubMed ID: 20466142
[TBL] [Abstract][Full Text] [Related]
8. Free energy calculations on the binding of colchicine and its derivatives with the alpha/beta-tubulin isoforms.
Mane JY; Klobukowski M; Huzil JT; Tuszynski J
J Chem Inf Model; 2008 Sep; 48(9):1824-32. PubMed ID: 18712858
[TBL] [Abstract][Full Text] [Related]
9. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain.
Ravelli RB; Gigant B; Curmi PA; Jourdain I; Lachkar S; Sobel A; Knossow M
Nature; 2004 Mar; 428(6979):198-202. PubMed ID: 15014504
[TBL] [Abstract][Full Text] [Related]
10. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin.
Bhattacharyya B; Panda D; Gupta S; Banerjee M
Med Res Rev; 2008 Jan; 28(1):155-83. PubMed ID: 17464966
[TBL] [Abstract][Full Text] [Related]
11. Sulfonamide drugs binding to the colchicine site of tubulin: thermodynamic analysis of the drug-tubulin interactions by isothermal titration calorimetry.
Banerjee M; Poddar A; Mitra G; Surolia A; Owa T; Bhattacharyya B
J Med Chem; 2005 Jan; 48(2):547-55. PubMed ID: 15658868
[TBL] [Abstract][Full Text] [Related]
12. Linkages in tubulin-colchicine functions: the role of the ring C (C') oxygens and ring B in the controls.
Pérez-Ramírez B; Gorbunoff MJ; Timasheff SN
Biochemistry; 1998 Feb; 37(6):1646-61. PubMed ID: 9484236
[TBL] [Abstract][Full Text] [Related]
13. Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures.
Li W; Sun H; Xu S; Zhu Z; Xu J
Future Med Chem; 2017 Oct; 9(15):1765-1794. PubMed ID: 28929799
[TBL] [Abstract][Full Text] [Related]
14. -NH-dansyl isocolchicine exhibits a significantly improved tubulin-binding affinity and microtubule inhibition in comparison to isocolchicine by binding tubulin through its A and B rings.
Das L; Datta AB; Gupta S; Poddar A; Sengupta S; Janik ME; Bhattacharyya B
Biochemistry; 2005 Mar; 44(9):3249-58. PubMed ID: 15736935
[TBL] [Abstract][Full Text] [Related]
15. Computational design and biological testing of highly cytotoxic colchicine ring A modifications.
Torin Huzil J; Winter P; Johnson L; Weis AL; Bakos T; Banerjee A; Luduena RF; Damaraju S; Tuszynski JA
Chem Biol Drug Des; 2010 Jun; 75(6):541-50. PubMed ID: 20408852
[TBL] [Abstract][Full Text] [Related]
16. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.
Coluccia A; Sabbadin D; Brancale A
Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885
[TBL] [Abstract][Full Text] [Related]
17. Colchicine binding to tubulin monomers: a mechanistic study.
Banerjee S; Chakrabarti G; Bhattacharyya B
Biochemistry; 1997 May; 36(18):5600-6. PubMed ID: 9154944
[TBL] [Abstract][Full Text] [Related]
18. Structural insight into the role of Gln293Met mutation on the Peloruside A/Laulimalide association with αβ-tubulin from molecular dynamics simulations, binding free energy calculations and weak interactions analysis.
Zúñiga MA; Alderete JB; Jaña GA; Jiménez VA
J Comput Aided Mol Des; 2017 Jul; 31(7):643-652. PubMed ID: 28597356
[TBL] [Abstract][Full Text] [Related]
19. IKP104-induced decay of tubulin: role of the A-ring binding site of colchicine.
Chaudhuri AR; Tomita I; Mizuhashi F; Murata K; Potenziano JL; Ludueña RF
Biochemistry; 1998 Dec; 37(49):17157-62. PubMed ID: 9860828
[TBL] [Abstract][Full Text] [Related]
20. A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach.
Nguyen TL; McGrath C; Hermone AR; Burnett JC; Zaharevitz DW; Day BW; Wipf P; Hamel E; Gussio R
J Med Chem; 2005 Sep; 48(19):6107-16. PubMed ID: 16162011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
